Cytokinetics, Incorporated
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Cytokinetics, Incorporated's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 92% to $7,530,000. Profit margin reached -6989%. Total operating expenses were $173,612,000.
Profit Margin
| 2014 | 46.94M | -14.64M | -31.2% |
|---|---|---|---|
| 2015 | 28.65M | -37.50M | -130.86% |
| 2016 | 106.40M | 16.45M | 15.46% |
| 2017 | 13.36M | -127.79M | -955.94% |
| 2018 | 31.50M | -106.28M | -337.41% |
| 2019 | 26.86M | -149.05M | -554.76% |
| 2020 | 55.82M | -164.13M | -294% |
| 2021 | 70.42M | -242.37M | -344.14% |
| 2022 | 94.58M | -402.55M | -425.58% |
| 2023 | 7.53M | -526.24M | -6988.63% |
CYTK Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 7.53M | 94.58M | 70.42M | 55.82M | 26.86M | 31.50M | 13.36M | 106.40M | 28.65M | 46.94M |
Cost of revenue | 330.12M | 240.81M | 159.93M | 96.95M | 86.12M | 89.13M | 90.29M | 59.89M | 46.39M | 44.42M |
Gross profit | -322.59M | -146.22M | -89.51M | -41.12M | -59.25M | -57.63M | -76.92M | 46.51M | -17.74M | 2.51M |
Operating exp. | ||||||||||
Research and development | 0 | 6.58M | 159.93M | 96.95M | 86.12M | 89.13M | 90.29M | 59.89M | 46.39M | 44.42M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 173.61M | 177.97M | 96.80M | 52.82M | 39.61M | 31.28M | 36.46M | 27.82M | 19.66M | 17.26M |
Operating income | -496.20M | -324.20M | -186.31M | -93.94M | -98.86M | -88.91M | -113.39M | 18.68M | -37.40M | -14.75M |
Other income (expenses), net | -30.03M | -64.75M | -29.00M | -33.34M | -22.82M | -17.37M | -14.39M | -2.23M | -94K | 108K |
Income before tax | -526.24M | -388.95M | -215.31M | -127.29M | -121.69M | -106.28M | -127.79M | 16.45M | -37.50M | -14.64M |
Income tax expense | 0 | 13.59M | 27.05M | 36.84M | 27.36M | 4.19M | 682K | -741K | -589K | -490K |
Net income | -526.24M | -402.55M | -242.37M | -164.13M | -149.05M | -106.28M | -127.79M | 16.45M | -37.50M | -14.64M |
Earnings per share | ||||||||||
Basic EPS | -5.45 | -4.48 | -3.15 | -2.54 | -2.59 | -1.95 | -2.59 | 0.41 | -0.97 | -0.41 |
Diluted EPS | -5.45 | -4.48 | -3.15 | -2.54 | -2.59 | -1.95 | -2.59 | 0.39 | -0.97 | -0.41 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |